On October 4, 2023 OncoBone Ventures reported that the company attends AACR (Free AACR Whitepaper)-NCI-EORTC oncology scientific event in Boston, MA, during October 11-15 and presents a poster titled: ‘Preclinical Bone Metastasis Technology Platform – Predictive evaluation of Experimental Therapies on Bone Metastasis’ (Press release, OncoBone Ventures, OCT 4, 2023, View Source [SID1234636479]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The Preclinical Bone Metastasis Technology Platform is a key in drug development activities of OncoBone Ventures that will be utilized to evaluate effects of pipeline therapeutic assets on bone metastases.
If you are interested to learn more, please visit the poster A007 on October 12 at 12:30 – 4:00 pm at the event or reach out via View Source